

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.43538366 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.38610392 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.18422437 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 6.18422437 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.70353788 |
| 6 | proteasome assembly (GO:0043248) | 5.51465697 |
| 7 | regulation of protein kinase A signaling (GO:0010738) | 5.32946288 |
| 8 | respiratory electron transport chain (GO:0022904) | 5.29213725 |
| 9 | electron transport chain (GO:0022900) | 5.17124214 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 4.86438045 |
| 11 | vocalization behavior (GO:0071625) | 4.74708091 |
| 12 | termination of RNA polymerase III transcription (GO:0006386) | 4.41170296 |
| 13 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.41170296 |
| 14 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.37868573 |
| 15 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.33695421 |
| 16 | dopamine biosynthetic process (GO:0042416) | 4.27082863 |
| 17 | neurotransmitter catabolic process (GO:0042135) | 4.21470839 |
| 18 | mating behavior (GO:0007617) | 4.19138591 |
| 19 | dopamine transport (GO:0015872) | 4.13976198 |
| 20 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12222488 |
| 21 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.08239960 |
| 22 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.05243538 |
| 23 | neuron recognition (GO:0008038) | 4.05117328 |
| 24 | positive regulation of synapse assembly (GO:0051965) | 4.04703576 |
| 25 | respiratory chain complex IV assembly (GO:0008535) | 4.04594811 |
| 26 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.01503351 |
| 27 | negative regulation of ligase activity (GO:0051352) | 4.01503351 |
| 28 | chaperone-mediated protein transport (GO:0072321) | 4.00863066 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 3.89549924 |
| 30 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.87762970 |
| 31 | protein localization to synapse (GO:0035418) | 3.84481707 |
| 32 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.83641661 |
| 33 | * protein targeting to mitochondrion (GO:0006626) | 3.80733410 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80173152 |
| 35 | cytochrome complex assembly (GO:0017004) | 3.79449231 |
| 36 | * establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.79220389 |
| 37 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.74183855 |
| 38 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.74183855 |
| 39 | rRNA modification (GO:0000154) | 3.73475437 |
| 40 | transmission of nerve impulse (GO:0019226) | 3.71081781 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.69549261 |
| 42 | protein deneddylation (GO:0000338) | 3.66198895 |
| 43 | cullin deneddylation (GO:0010388) | 3.65453705 |
| 44 | GTP biosynthetic process (GO:0006183) | 3.63164298 |
| 45 | response to histamine (GO:0034776) | 3.62753612 |
| 46 | opioid receptor signaling pathway (GO:0038003) | 3.60941622 |
| 47 | establishment of integrated proviral latency (GO:0075713) | 3.60067601 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.59857856 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.59643637 |
| 50 | * establishment of protein localization to mitochondrion (GO:0072655) | 3.59337932 |
| 51 | * protein localization to mitochondrion (GO:0070585) | 3.59158946 |
| 52 | chromatin remodeling at centromere (GO:0031055) | 3.57088138 |
| 53 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.55454887 |
| 54 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.55454887 |
| 55 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.55454887 |
| 56 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.55004070 |
| 57 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.53743481 |
| 58 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.53743481 |
| 59 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.53219386 |
| 60 | CENP-A containing nucleosome assembly (GO:0034080) | 3.52529478 |
| 61 | DNA damage response, detection of DNA damage (GO:0042769) | 3.51787977 |
| 62 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.51039603 |
| 63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.51039603 |
| 64 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.48963507 |
| 65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48746798 |
| 66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.48004429 |
| 67 | hydrogen ion transmembrane transport (GO:1902600) | 3.46813469 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.45597214 |
| 69 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.44638486 |
| 70 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44139484 |
| 71 | neuron remodeling (GO:0016322) | 3.43994232 |
| 72 | neurotransmitter biosynthetic process (GO:0042136) | 3.43981623 |
| 73 | glutamate receptor signaling pathway (GO:0007215) | 3.43939844 |
| 74 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.43281351 |
| 75 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.43281351 |
| 76 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.39525226 |
| 77 | regulation of glutamate secretion (GO:0014048) | 3.38657686 |
| 78 | positive regulation of ligase activity (GO:0051351) | 3.37913041 |
| 79 | protein localization to cilium (GO:0061512) | 3.34168023 |
| 80 | axon ensheathment in central nervous system (GO:0032291) | 3.30546967 |
| 81 | central nervous system myelination (GO:0022010) | 3.30546967 |
| 82 | synaptic transmission, dopaminergic (GO:0001963) | 3.30295693 |
| 83 | spliceosomal snRNP assembly (GO:0000387) | 3.29864004 |
| 84 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.28761386 |
| 85 | protein-cofactor linkage (GO:0018065) | 3.27807705 |
| 86 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26565231 |
| 87 | metallo-sulfur cluster assembly (GO:0031163) | 3.25619748 |
| 88 | iron-sulfur cluster assembly (GO:0016226) | 3.25619748 |
| 89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25387658 |
| 90 | DNA deamination (GO:0045006) | 3.25295880 |
| 91 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23672052 |
| 92 | protein neddylation (GO:0045116) | 3.23437157 |
| 93 | neuronal action potential propagation (GO:0019227) | 3.23023988 |
| 94 | regulation of catecholamine metabolic process (GO:0042069) | 3.22789260 |
| 95 | regulation of dopamine metabolic process (GO:0042053) | 3.22789260 |
| 96 | ATP biosynthetic process (GO:0006754) | 3.18931983 |
| 97 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.17676455 |
| 98 | neurotransmitter transport (GO:0006836) | 3.16153871 |
| 99 | neurotransmitter secretion (GO:0007269) | 3.16052416 |
| 100 | proton transport (GO:0015992) | 3.15475365 |
| 101 | regulation of vesicle fusion (GO:0031338) | 3.15183554 |
| 102 | peptidyl-histidine modification (GO:0018202) | 3.13449624 |
| 103 | neuron-neuron synaptic transmission (GO:0007270) | 3.12249007 |
| 104 | regulation of ligase activity (GO:0051340) | 3.12035222 |
| 105 | catecholamine transport (GO:0051937) | 3.11766592 |
| 106 | establishment of viral latency (GO:0019043) | 3.11346413 |
| 107 | hydrogen transport (GO:0006818) | 3.11085088 |
| 108 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.10243063 |
| 109 | cilium movement (GO:0003341) | 3.08749926 |
| 110 | ribosome assembly (GO:0042255) | 3.06966896 |
| 111 | cellular component biogenesis (GO:0044085) | 3.06779181 |
| 112 | female mating behavior (GO:0060180) | 3.05720331 |
| 113 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.04904350 |
| 114 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.04477241 |
| 115 | oxygen transport (GO:0015671) | 3.03247299 |
| 116 | protein K6-linked ubiquitination (GO:0085020) | 3.02970707 |
| 117 | rRNA methylation (GO:0031167) | 3.02668852 |
| 118 | rRNA processing (GO:0006364) | 3.01708448 |
| 119 | maturation of 5.8S rRNA (GO:0000460) | 3.01538260 |
| 120 | regulation of neurotransmitter levels (GO:0001505) | 3.00154006 |
| 121 | detection of calcium ion (GO:0005513) | 3.00061733 |
| 122 | protein complex biogenesis (GO:0070271) | 2.99765002 |
| 123 | UTP biosynthetic process (GO:0006228) | 2.98741543 |
| 124 | negative regulation of neurotransmitter transport (GO:0051589) | 2.98233741 |
| 125 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.97822226 |
| 126 | synapse assembly (GO:0007416) | 2.97637447 |
| 127 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.97554632 |
| 128 | base-excision repair, AP site formation (GO:0006285) | 2.97054955 |
| 129 | tRNA processing (GO:0008033) | 2.96675496 |
| 130 | 7-methylguanosine mRNA capping (GO:0006370) | 2.95063173 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94744530 |
| 132 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.93898695 |
| 133 | axonal fasciculation (GO:0007413) | 2.93725767 |
| 134 | histone exchange (GO:0043486) | 2.90120259 |
| 135 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.89738720 |
| 136 | glutamate secretion (GO:0014047) | 2.89696894 |
| 137 | regulation of synapse assembly (GO:0051963) | 2.89587730 |
| 138 | tRNA metabolic process (GO:0006399) | 2.87819881 |
| 139 | rRNA metabolic process (GO:0016072) | 2.87722704 |
| 140 | DNA strand elongation (GO:0022616) | 2.87479888 |
| 141 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.87217772 |
| 142 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.86445739 |
| 143 | 7-methylguanosine RNA capping (GO:0009452) | 2.86374718 |
| 144 | RNA capping (GO:0036260) | 2.86374718 |
| 145 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.85640514 |
| 146 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84882109 |
| 147 | regulation of cellular amine metabolic process (GO:0033238) | 2.84702311 |
| 148 | translation (GO:0006412) | 2.84213945 |
| 149 | oxidative phosphorylation (GO:0006119) | 2.83295873 |
| 150 | righting reflex (GO:0060013) | 2.83250145 |
| 151 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.82463627 |
| 152 | postsynaptic membrane organization (GO:0001941) | 2.81664348 |
| 153 | * intracellular protein transmembrane import (GO:0044743) | 2.81353517 |
| 154 | startle response (GO:0001964) | 2.80853398 |
| 155 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.80553753 |
| 156 | * mitochondrial transport (GO:0006839) | 2.80540937 |
| 157 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80394197 |
| 158 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.79804149 |
| 159 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.79804149 |
| 160 | NADH dehydrogenase complex assembly (GO:0010257) | 2.79804149 |
| 161 | negative regulation of protein ubiquitination (GO:0031397) | 2.79247287 |
| 162 | DNA replication checkpoint (GO:0000076) | 2.78994872 |
| 163 | dendritic spine morphogenesis (GO:0060997) | 2.78918237 |
| 164 | multi-organism reproductive behavior (GO:0044705) | 2.78302140 |
| 165 | response to cocaine (GO:0042220) | 2.78251005 |
| 166 | locomotory exploration behavior (GO:0035641) | 2.77734399 |
| 167 | substantia nigra development (GO:0021762) | 2.76927680 |
| 168 | mitochondrial RNA metabolic process (GO:0000959) | 2.76775265 |
| 169 | ribosomal small subunit assembly (GO:0000028) | 2.76485180 |
| 170 | neuropeptide signaling pathway (GO:0007218) | 2.76404459 |
| 171 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.76368074 |
| 172 | positive regulation of cell cycle arrest (GO:0071158) | 2.75921688 |
| 173 | DNA double-strand break processing (GO:0000729) | 2.75909808 |
| 174 | synaptic transmission, glutamatergic (GO:0035249) | 2.74683023 |
| 175 | transferrin transport (GO:0033572) | 2.74394058 |
| 176 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.74296528 |
| 177 | tRNA aminoacylation (GO:0043039) | 2.73861931 |
| 178 | amino acid activation (GO:0043038) | 2.73861931 |
| 179 | striatum development (GO:0021756) | 2.73696431 |
| 180 | mitotic metaphase plate congression (GO:0007080) | 2.73560196 |
| 181 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.72682574 |
| 182 | exploration behavior (GO:0035640) | 2.70666946 |
| 183 | positive regulation of amino acid transport (GO:0051957) | 2.70555554 |
| 184 | synaptic transmission, cholinergic (GO:0007271) | 2.70282133 |
| 185 | reproductive behavior (GO:0019098) | 2.69053801 |
| 186 | neurotransmitter metabolic process (GO:0042133) | 2.68786431 |
| 187 | long-term memory (GO:0007616) | 2.65865317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.07904615 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.39343170 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.58263032 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.19660596 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.17989134 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.65890227 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.60131416 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.56622362 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.52768876 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.47769875 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.47668696 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25361922 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.23483745 |
| 14 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.23225763 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.01220434 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92066514 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91108144 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81037006 |
| 19 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.80849400 |
| 20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.78739166 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77663331 |
| 22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.60883249 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.58815851 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.56527395 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55737861 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.52110199 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.51056405 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.49064679 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.48783091 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47332085 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43825386 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.43395969 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.42345931 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38099043 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.37931112 |
| 36 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.37174505 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34918665 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34123030 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34123030 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.34098023 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.34038473 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32418478 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31415023 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31134355 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30103278 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.27339488 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.16731878 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.15744786 |
| 49 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13418069 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13373129 |
| 51 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.12876582 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12618536 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.11003618 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09827174 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.09045686 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08741873 |
| 57 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06601165 |
| 58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.05936787 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05494976 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01617579 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01481235 |
| 62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99280948 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94052121 |
| 64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.93384325 |
| 65 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.93208582 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88887488 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.87758277 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.87020544 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86961377 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86663841 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81191275 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78539971 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78405452 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.75459989 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74533874 |
| 76 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74464648 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74140265 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73860918 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72266380 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69442444 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66870605 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.65536490 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.65426183 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65174617 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.64529149 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63721243 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59386074 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58080209 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55434930 |
| 90 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53489425 |
| 91 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53210624 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52721509 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51681712 |
| 94 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.51196768 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48971943 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47362458 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46188123 |
| 98 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.46048715 |
| 99 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44952865 |
| 100 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43238517 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40591415 |
| 102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37072179 |
| 103 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36947346 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35863067 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35665479 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34517452 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33921612 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.31759200 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31172079 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30172567 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29648865 |
| 112 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28951319 |
| 113 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25413429 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.23835819 |
| 115 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23393092 |
| 116 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22795895 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21769295 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 1.21612818 |
| 119 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21587855 |
| 120 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20979761 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19857871 |
| 122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18266893 |
| 123 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.17955376 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17544828 |
| 125 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17405901 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.16335906 |
| 127 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16271607 |
| 128 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15680642 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14016973 |
| 130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13231061 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12492530 |
| 132 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.10999004 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09337272 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09278379 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08862856 |
| 136 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07784323 |
| 137 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06842698 |
| 138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06824256 |
| 139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06542689 |
| 140 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06086881 |
| 141 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.05267112 |
| 142 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04253828 |
| 143 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04030014 |
| 144 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03838535 |
| 145 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.03756127 |
| 146 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03621880 |
| 147 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02472300 |
| 148 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02123606 |
| 149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02036812 |
| 150 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01539408 |
| 151 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01192845 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00609248 |
| 153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00545061 |
| 154 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00379505 |
| 155 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99718348 |
| 156 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99505846 |
| 157 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.99484868 |
| 158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98787939 |
| 159 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98757247 |
| 160 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98111167 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96688514 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96630786 |
| 163 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96107206 |
| 164 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95950534 |
| 165 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93325196 |
| 166 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93154662 |
| 167 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92959190 |
| 168 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92132448 |
| 169 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91914088 |
| 170 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.91086469 |
| 171 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90594077 |
| 172 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89905503 |
| 173 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89788386 |
| 174 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.88139247 |
| 175 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87745870 |
| 176 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.86516466 |
| 177 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84793499 |
| 178 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.84554902 |
| 179 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82612484 |
| 180 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.80667617 |
| 181 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.80358518 |
| 182 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80344505 |
| 183 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79190599 |
| 184 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.77235994 |
| 185 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.76597614 |
| 186 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76210986 |
| 187 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75337548 |
| 188 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72732507 |
| 189 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.72532762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.24321589 |
| 2 | MP0008058_abnormal_DNA_repair | 3.83232630 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.64612073 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.37162370 |
| 5 | MP0001529_abnormal_vocalization | 3.35072701 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.22121613 |
| 7 | MP0009046_muscle_twitch | 3.11585997 |
| 8 | MP0002064_seizures | 3.07070716 |
| 9 | MP0009745_abnormal_behavioral_response | 3.05122741 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 3.01758468 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.99449720 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.96855015 |
| 13 | MP0003122_maternal_imprinting | 2.90418543 |
| 14 | MP0001440_abnormal_grooming_behavior | 2.90191715 |
| 15 | MP0001905_abnormal_dopamine_level | 2.85155750 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.84179350 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.76997600 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.65813968 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.61367878 |
| 20 | MP0002736_abnormal_nociception_after | 2.61324750 |
| 21 | MP0003786_premature_aging | 2.61304017 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.59038254 |
| 23 | MP0004142_abnormal_muscle_tone | 2.53415160 |
| 24 | MP0008932_abnormal_embryonic_tissue | 2.52734166 |
| 25 | MP0002272_abnormal_nervous_system | 2.46061827 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.44367327 |
| 27 | MP0002063_abnormal_learning/memory/cond | 2.44166682 |
| 28 | MP0003718_maternal_effect | 2.43500756 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.32812151 |
| 30 | MP0003186_abnormal_redox_activity | 2.32558826 |
| 31 | MP0003077_abnormal_cell_cycle | 2.32366529 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 2.27335009 |
| 33 | MP0002735_abnormal_chemical_nociception | 2.22117551 |
| 34 | MP0001486_abnormal_startle_reflex | 2.18502349 |
| 35 | MP0008007_abnormal_cellular_replicative | 2.16453642 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 2.15549332 |
| 37 | MP0002067_abnormal_sensory_capabilities | 2.07463902 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 2.00480482 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.99486537 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.99085163 |
| 41 | MP0004270_analgesia | 1.98482145 |
| 42 | MP0001970_abnormal_pain_threshold | 1.89833280 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.85856789 |
| 44 | MP0004924_abnormal_behavior | 1.85437813 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.85437813 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.84524379 |
| 47 | MP0002938_white_spotting | 1.83449047 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.82942763 |
| 49 | MP0001188_hyperpigmentation | 1.79336770 |
| 50 | MP0000778_abnormal_nervous_system | 1.77819108 |
| 51 | MP0002184_abnormal_innervation | 1.72545105 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.71571875 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.70755866 |
| 54 | MP0002822_catalepsy | 1.62018888 |
| 55 | MP0005379_endocrine/exocrine_gland_phen | 1.59395428 |
| 56 | MP0005409_darkened_coat_color | 1.56813767 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.56588147 |
| 58 | MP0000358_abnormal_cell_content/ | 1.55671401 |
| 59 | MP0001984_abnormal_olfaction | 1.52293378 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.49796766 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.46206526 |
| 62 | MP0003329_amyloid_beta_deposits | 1.44878773 |
| 63 | MP0004742_abnormal_vestibular_system | 1.41279377 |
| 64 | MP0002160_abnormal_reproductive_system | 1.39524270 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.37366438 |
| 66 | MP0003011_delayed_dark_adaptation | 1.37267325 |
| 67 | MP0001293_anophthalmia | 1.36576377 |
| 68 | MP0004133_heterotaxia | 1.35010666 |
| 69 | MP0003941_abnormal_skin_development | 1.32618098 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.32228615 |
| 71 | MP0000751_myopathy | 1.30441689 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.30244814 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28721221 |
| 74 | MP0002210_abnormal_sex_determination | 1.27346383 |
| 75 | MP0009697_abnormal_copulation | 1.25969885 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.22493044 |
| 77 | MP0001502_abnormal_circadian_rhythm | 1.20611610 |
| 78 | MP0002882_abnormal_neuron_morphology | 1.19231537 |
| 79 | MP0002163_abnormal_gland_morphology | 1.18628772 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.14032554 |
| 81 | MP0002234_abnormal_pharynx_morphology | 1.13619525 |
| 82 | MP0000749_muscle_degeneration | 1.13141058 |
| 83 | MP0008872_abnormal_physiological_respon | 1.12131066 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.12080383 |
| 85 | MP0003121_genomic_imprinting | 1.11817654 |
| 86 | MP0000955_abnormal_spinal_cord | 1.11462655 |
| 87 | MP0003136_yellow_coat_color | 1.11226007 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.11115064 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 1.10821015 |
| 90 | MP0008569_lethality_at_weaning | 1.05718264 |
| 91 | MP0001764_abnormal_homeostasis | 1.05535608 |
| 92 | MP0000920_abnormal_myelination | 1.02353942 |
| 93 | MP0003646_muscle_fatigue | 1.02154032 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 1.01666788 |
| 95 | MP0002638_abnormal_pupillary_reflex | 1.01418012 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 1.00634436 |
| 97 | MP0005535_abnormal_body_temperature | 1.00178833 |
| 98 | MP0008995_early_reproductive_senescence | 1.00046509 |
| 99 | MP0001730_embryonic_growth_arrest | 0.98152578 |
| 100 | MP0001929_abnormal_gametogenesis | 0.96793997 |
| 101 | MP0002102_abnormal_ear_morphology | 0.96735784 |
| 102 | MP0000049_abnormal_middle_ear | 0.96170430 |
| 103 | MP0002229_neurodegeneration | 0.95126926 |
| 104 | MP0000350_abnormal_cell_proliferation | 0.94409357 |
| 105 | MP0003690_abnormal_glial_cell | 0.94149406 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.94107160 |
| 107 | MP0003634_abnormal_glial_cell | 0.93755495 |
| 108 | MP0001145_abnormal_male_reproductive | 0.93355956 |
| 109 | MP0002752_abnormal_somatic_nervous | 0.92808385 |
| 110 | MP0000653_abnormal_sex_gland | 0.92371596 |
| 111 | MP0005171_absent_coat_pigmentation | 0.92053112 |
| 112 | MP0002233_abnormal_nose_morphology | 0.91899962 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.91869918 |
| 114 | MP0003119_abnormal_digestive_system | 0.91003226 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.90570701 |
| 116 | MP0002152_abnormal_brain_morphology | 0.90294927 |
| 117 | MP0001664_abnormal_digestion | 0.89496627 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.89349013 |
| 119 | MP0003315_abnormal_perineum_morphology | 0.87572189 |
| 120 | MP0005389_reproductive_system_phenotype | 0.84705173 |
| 121 | MP0005332_abnormal_amino_acid | 0.84547139 |
| 122 | MP0003123_paternal_imprinting | 0.84232029 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.83640862 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.82364763 |
| 125 | MP0002090_abnormal_vision | 0.81898018 |
| 126 | MP0004811_abnormal_neuron_physiology | 0.81668696 |
| 127 | MP0004085_abnormal_heartbeat | 0.80555158 |
| 128 | MP0001697_abnormal_embryo_size | 0.78755353 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.78737987 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.78329223 |
| 131 | MP0002069_abnormal_eating/drinking_beha | 0.77695253 |
| 132 | MP0002085_abnormal_embryonic_tissue | 0.74042844 |
| 133 | MP0005253_abnormal_eye_physiology | 0.73965651 |
| 134 | MP0000747_muscle_weakness | 0.73419585 |
| 135 | MP0000026_abnormal_inner_ear | 0.72810413 |
| 136 | MP0005367_renal/urinary_system_phenotyp | 0.72037408 |
| 137 | MP0000516_abnormal_urinary_system | 0.72037408 |
| 138 | MP0000313_abnormal_cell_death | 0.71672729 |
| 139 | MP0002080_prenatal_lethality | 0.71654237 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.71395744 |
| 141 | MP0002084_abnormal_developmental_patter | 0.70842349 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.70750292 |
| 143 | MP0003698_abnormal_male_reproductive | 0.70593144 |
| 144 | MP0004272_abnormal_basement_membrane | 0.70292910 |
| 145 | MP0003633_abnormal_nervous_system | 0.69363911 |
| 146 | MP0004215_abnormal_myocardial_fiber | 0.68815526 |
| 147 | MP0001943_abnormal_respiration | 0.68453323 |
| 148 | MP0003283_abnormal_digestive_organ | 0.68288321 |
| 149 | MP0005410_abnormal_fertilization | 0.68251454 |
| 150 | MP0004147_increased_porphyrin_level | 0.68151314 |
| 151 | MP0008057_abnormal_DNA_replication | 0.66768589 |
| 152 | MP0002751_abnormal_autonomic_nervous | 0.66539513 |
| 153 | MP0003631_nervous_system_phenotype | 0.66257554 |
| 154 | MP0005380_embryogenesis_phenotype | 0.65433411 |
| 155 | MP0001672_abnormal_embryogenesis/_devel | 0.65433411 |
| 156 | MP0005394_taste/olfaction_phenotype | 0.64840625 |
| 157 | MP0005499_abnormal_olfactory_system | 0.64840625 |
| 158 | MP0001119_abnormal_female_reproductive | 0.64223467 |
| 159 | MP0001286_abnormal_eye_development | 0.63332015 |
| 160 | MP0003787_abnormal_imprinting | 0.60377308 |
| 161 | MP0003879_abnormal_hair_cell | 0.60033934 |
| 162 | MP0004858_abnormal_nervous_system | 0.59027471 |
| 163 | MP0008874_decreased_physiological_sensi | 0.58878538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.46248767 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.40319845 |
| 3 | Progressive macrocephaly (HP:0004481) | 4.74841805 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.72903435 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.55162787 |
| 6 | Limb dystonia (HP:0002451) | 4.48788473 |
| 7 | Abnormal ciliary motility (HP:0012262) | 4.29322598 |
| 8 | Acute encephalopathy (HP:0006846) | 4.21872980 |
| 9 | Focal seizures (HP:0007359) | 3.89787037 |
| 10 | Atonic seizures (HP:0010819) | 3.87533208 |
| 11 | Visual hallucinations (HP:0002367) | 3.86850495 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.72694883 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.72694883 |
| 14 | Increased CSF lactate (HP:0002490) | 3.65056072 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.59801538 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.57597921 |
| 17 | Absence seizures (HP:0002121) | 3.48906106 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.40190813 |
| 19 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.40190813 |
| 20 | Increased serum lactate (HP:0002151) | 3.37458746 |
| 21 | Dialeptic seizures (HP:0011146) | 3.36242438 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.33722503 |
| 23 | Myokymia (HP:0002411) | 3.32523789 |
| 24 | Microvesicular hepatic steatosis (HP:0001414) | 3.32296214 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 3.31533779 |
| 26 | Optic disc pallor (HP:0000543) | 3.28307238 |
| 27 | Gait imbalance (HP:0002141) | 3.12774352 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 2.95607870 |
| 29 | Increased serum pyruvate (HP:0003542) | 2.95383357 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.94943763 |
| 31 | Abnormality of glycolysis (HP:0004366) | 2.94404475 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.93013183 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 2.91812358 |
| 34 | Abnormal number of erythroid precursors (HP:0012131) | 2.91151398 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.90694426 |
| 36 | Abnormality of the labia minora (HP:0012880) | 2.90569935 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.89744131 |
| 38 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.89744131 |
| 39 | Medial flaring of the eyebrow (HP:0010747) | 2.87324118 |
| 40 | Polyphagia (HP:0002591) | 2.86253976 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.86026634 |
| 42 | Rhinitis (HP:0012384) | 2.85108265 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.84194415 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.79762640 |
| 45 | Cerebral edema (HP:0002181) | 2.79139141 |
| 46 | Pheochromocytoma (HP:0002666) | 2.77733581 |
| 47 | Leukodystrophy (HP:0002415) | 2.77255545 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.72532259 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.69992762 |
| 50 | Methylmalonic aciduria (HP:0012120) | 2.69874592 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.69869401 |
| 52 | Methylmalonic acidemia (HP:0002912) | 2.69817104 |
| 53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.69230613 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.68639642 |
| 55 | Vaginal atresia (HP:0000148) | 2.68260854 |
| 56 | Genital tract atresia (HP:0001827) | 2.67785533 |
| 57 | Broad-based gait (HP:0002136) | 2.66437313 |
| 58 | Febrile seizures (HP:0002373) | 2.63485865 |
| 59 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.60710245 |
| 60 | Progressive inability to walk (HP:0002505) | 2.59081912 |
| 61 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.57636654 |
| 62 | Exercise intolerance (HP:0003546) | 2.55827861 |
| 63 | Nephrogenic diabetes insipidus (HP:0009806) | 2.55642165 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52842992 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52842992 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.52842992 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.52842992 |
| 68 | Abnormal pupillary function (HP:0007686) | 2.51993776 |
| 69 | Hyperventilation (HP:0002883) | 2.48619552 |
| 70 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.47490963 |
| 71 | Exertional dyspnea (HP:0002875) | 2.46050891 |
| 72 | Anxiety (HP:0000739) | 2.42663992 |
| 73 | Sensory axonal neuropathy (HP:0003390) | 2.42254154 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41828869 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41828869 |
| 76 | Respiratory failure (HP:0002878) | 2.41090325 |
| 77 | Hypothermia (HP:0002045) | 2.40479155 |
| 78 | Colon cancer (HP:0003003) | 2.39193667 |
| 79 | Hyperglycinemia (HP:0002154) | 2.37813306 |
| 80 | Molar tooth sign on MRI (HP:0002419) | 2.35782223 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.35782223 |
| 82 | Infantile muscular hypotonia (HP:0008947) | 2.35564640 |
| 83 | Amblyopia (HP:0000646) | 2.31925117 |
| 84 | Cerebral hemorrhage (HP:0001342) | 2.31291942 |
| 85 | Lethargy (HP:0001254) | 2.30262301 |
| 86 | Failure to thrive in infancy (HP:0001531) | 2.28905064 |
| 87 | Respiratory difficulties (HP:0002880) | 2.28541775 |
| 88 | Hyperthyroidism (HP:0000836) | 2.27150839 |
| 89 | Esotropia (HP:0000565) | 2.26805204 |
| 90 | Abnormal hair whorl (HP:0010721) | 2.26462827 |
| 91 | Mutism (HP:0002300) | 2.23686847 |
| 92 | Abnormal eating behavior (HP:0100738) | 2.21395639 |
| 93 | Hepatic necrosis (HP:0002605) | 2.21131736 |
| 94 | Retinal dysplasia (HP:0007973) | 2.21070848 |
| 95 | X-linked dominant inheritance (HP:0001423) | 2.20329570 |
| 96 | Delusions (HP:0000746) | 2.20139686 |
| 97 | Hyperalaninemia (HP:0003348) | 2.17978456 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17978456 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 2.17978456 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15604807 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 2.15249223 |
| 102 | Abnormality of the corticospinal tract (HP:0002492) | 2.14564991 |
| 103 | CNS demyelination (HP:0007305) | 2.12290231 |
| 104 | Cerebral hypomyelination (HP:0006808) | 2.09425084 |
| 105 | Abnormality of placental membranes (HP:0011409) | 2.06428778 |
| 106 | Amniotic constriction ring (HP:0009775) | 2.06428778 |
| 107 | Dysmetria (HP:0001310) | 2.05963844 |
| 108 | Synostosis involving the elbow (HP:0003938) | 2.04760949 |
| 109 | Humeroradial synostosis (HP:0003041) | 2.04760949 |
| 110 | Pancreatic cysts (HP:0001737) | 2.02923908 |
| 111 | Pancreatic fibrosis (HP:0100732) | 2.01376378 |
| 112 | Neoplasm of the adrenal gland (HP:0100631) | 2.00690201 |
| 113 | Psychosis (HP:0000709) | 2.00532987 |
| 114 | Delayed gross motor development (HP:0002194) | 2.00367767 |
| 115 | Specific learning disability (HP:0001328) | 2.00185801 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 1.98629787 |
| 117 | Degeneration of anterior horn cells (HP:0002398) | 1.97816584 |
| 118 | Abnormality of the anterior horn cell (HP:0006802) | 1.97816584 |
| 119 | Lactic acidosis (HP:0003128) | 1.96402200 |
| 120 | Multiple enchondromatosis (HP:0005701) | 1.95693870 |
| 121 | Reticulocytopenia (HP:0001896) | 1.95233982 |
| 122 | Poor coordination (HP:0002370) | 1.94713289 |
| 123 | Hypoplastic pelvis (HP:0008839) | 1.90646131 |
| 124 | Drooling (HP:0002307) | 1.89652750 |
| 125 | Excessive salivation (HP:0003781) | 1.89652750 |
| 126 | Hypoventilation (HP:0002791) | 1.89395556 |
| 127 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89250329 |
| 128 | Generalized myoclonic seizures (HP:0002123) | 1.87310390 |
| 129 | Meckel diverticulum (HP:0002245) | 1.85492442 |
| 130 | Testicular atrophy (HP:0000029) | 1.85262446 |
| 131 | Poor suck (HP:0002033) | 1.85004328 |
| 132 | Abnormality of renal resorption (HP:0011038) | 1.84630725 |
| 133 | Peripheral hypomyelination (HP:0007182) | 1.83295071 |
| 134 | Hemiparesis (HP:0001269) | 1.83117742 |
| 135 | Progressive external ophthalmoplegia (HP:0000590) | 1.82242561 |
| 136 | Adrenal hypoplasia (HP:0000835) | 1.82033493 |
| 137 | Supranuclear gaze palsy (HP:0000605) | 1.82019760 |
| 138 | Macrocytic anemia (HP:0001972) | 1.81960324 |
| 139 | Opisthotonus (HP:0002179) | 1.81910027 |
| 140 | Progressive microcephaly (HP:0000253) | 1.80808044 |
| 141 | True hermaphroditism (HP:0010459) | 1.80578231 |
| 142 | Diplopia (HP:0000651) | 1.80302071 |
| 143 | Abnormality of binocular vision (HP:0011514) | 1.80302071 |
| 144 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78639182 |
| 145 | Aplastic anemia (HP:0001915) | 1.78611166 |
| 146 | Parakeratosis (HP:0001036) | 1.77900111 |
| 147 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.77187024 |
| 148 | Truncal ataxia (HP:0002078) | 1.76940556 |
| 149 | Emotional lability (HP:0000712) | 1.76522723 |
| 150 | Sclerocornea (HP:0000647) | 1.76356010 |
| 151 | Gaze-evoked nystagmus (HP:0000640) | 1.76165064 |
| 152 | Glycosuria (HP:0003076) | 1.74745413 |
| 153 | Abnormality of urine glucose concentration (HP:0011016) | 1.74745413 |
| 154 | Pancytopenia (HP:0001876) | 1.74097984 |
| 155 | Microretrognathia (HP:0000308) | 1.74025844 |
| 156 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.73933504 |
| 157 | Abnormality of the ileum (HP:0001549) | 1.73645199 |
| 158 | Sparse eyelashes (HP:0000653) | 1.72507130 |
| 159 | CNS hypomyelination (HP:0003429) | 1.70853671 |
| 160 | Birth length less than 3rd percentile (HP:0003561) | 1.70842787 |
| 161 | Muscle fiber atrophy (HP:0100295) | 1.70718100 |
| 162 | Reduced antithrombin III activity (HP:0001976) | 1.68900864 |
| 163 | Hyperphosphaturia (HP:0003109) | 1.68295035 |
| 164 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.67019091 |
| 165 | Dicarboxylic aciduria (HP:0003215) | 1.66912467 |
| 166 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66912467 |
| 167 | Prominent metopic ridge (HP:0005487) | 1.66572497 |
| 168 | Absent thumb (HP:0009777) | 1.64933366 |
| 169 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.64285037 |
| 170 | Nephronophthisis (HP:0000090) | 1.63475902 |
| 171 | Horseshoe kidney (HP:0000085) | 1.62747262 |
| 172 | Pendular nystagmus (HP:0012043) | 1.60873481 |
| 173 | Blindness (HP:0000618) | 1.60030218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PNCK | 5.50567327 |
| 2 | MAP3K12 | 4.37246848 |
| 3 | BUB1 | 4.19241242 |
| 4 | VRK2 | 4.08399185 |
| 5 | MAP4K2 | 3.80778359 |
| 6 | NTRK3 | 3.23616087 |
| 7 | CASK | 3.23322907 |
| 8 | ZAK | 2.75288581 |
| 9 | SRPK1 | 2.72358174 |
| 10 | BCKDK | 2.54186660 |
| 11 | ARAF | 2.28176993 |
| 12 | MAPKAPK5 | 2.24577588 |
| 13 | TNIK | 2.13576401 |
| 14 | TRIM28 | 2.13158069 |
| 15 | MAP3K9 | 2.09416672 |
| 16 | NME2 | 2.05349615 |
| 17 | NEK1 | 2.03082055 |
| 18 | NME1 | 2.02484610 |
| 19 | MARK1 | 2.00301170 |
| 20 | PLK3 | 1.95393106 |
| 21 | EIF2AK1 | 1.94577926 |
| 22 | NUAK1 | 1.90730763 |
| 23 | EPHA4 | 1.87821783 |
| 24 | MAP3K4 | 1.86545259 |
| 25 | TTK | 1.82514102 |
| 26 | PLK4 | 1.79089971 |
| 27 | STK39 | 1.78775064 |
| 28 | MINK1 | 1.76108268 |
| 29 | CDC7 | 1.75655991 |
| 30 | OXSR1 | 1.75154556 |
| 31 | FES | 1.73172668 |
| 32 | MAP2K7 | 1.72427751 |
| 33 | GRK5 | 1.66156269 |
| 34 | EIF2AK3 | 1.64773272 |
| 35 | CDK19 | 1.64284245 |
| 36 | MAP2K4 | 1.64156185 |
| 37 | NTRK2 | 1.63028713 |
| 38 | NTRK1 | 1.56710997 |
| 39 | GRK7 | 1.56425308 |
| 40 | ADRBK2 | 1.56080557 |
| 41 | RIPK4 | 1.54721570 |
| 42 | IRAK2 | 1.50841233 |
| 43 | TAF1 | 1.46009743 |
| 44 | PDK2 | 1.43606938 |
| 45 | MAPK15 | 1.42429841 |
| 46 | MAPK13 | 1.40490237 |
| 47 | DYRK2 | 1.36517267 |
| 48 | BCR | 1.32017610 |
| 49 | CAMK2A | 1.31353927 |
| 50 | PLK1 | 1.29534404 |
| 51 | CAMK2B | 1.28793139 |
| 52 | LIMK1 | 1.28237465 |
| 53 | FGR | 1.27681767 |
| 54 | BRSK2 | 1.27309156 |
| 55 | PIM2 | 1.25029002 |
| 56 | PLK2 | 1.24757132 |
| 57 | WEE1 | 1.23896327 |
| 58 | MYLK | 1.23106276 |
| 59 | BRSK1 | 1.22395822 |
| 60 | KDR | 1.16034838 |
| 61 | UHMK1 | 1.15421499 |
| 62 | CSNK1G3 | 1.15116730 |
| 63 | CSNK1G2 | 1.14132742 |
| 64 | LATS2 | 1.10923517 |
| 65 | MST4 | 1.10197891 |
| 66 | CAMK2D | 1.05032454 |
| 67 | CDK5 | 1.00492884 |
| 68 | SIK2 | 0.99717169 |
| 69 | TSSK6 | 0.98994833 |
| 70 | BMPR2 | 0.95520023 |
| 71 | PRKCG | 0.94593930 |
| 72 | STK16 | 0.94218530 |
| 73 | MAP3K13 | 0.94046313 |
| 74 | CCNB1 | 0.92501455 |
| 75 | TESK1 | 0.92132917 |
| 76 | CHEK2 | 0.91463546 |
| 77 | AURKA | 0.90451986 |
| 78 | PKN1 | 0.88460901 |
| 79 | MKNK1 | 0.88107940 |
| 80 | BMPR1B | 0.86473731 |
| 81 | ADRBK1 | 0.86393912 |
| 82 | CAMK2G | 0.85894477 |
| 83 | TESK2 | 0.85157257 |
| 84 | AURKB | 0.85086440 |
| 85 | PRKCE | 0.84830228 |
| 86 | PAK3 | 0.82509598 |
| 87 | WNK4 | 0.82439116 |
| 88 | GRK1 | 0.82010384 |
| 89 | CDK14 | 0.81306807 |
| 90 | ATR | 0.79979456 |
| 91 | CDK8 | 0.79135875 |
| 92 | TLK1 | 0.78441298 |
| 93 | MKNK2 | 0.77033364 |
| 94 | ROCK2 | 0.74524102 |
| 95 | CAMK1G | 0.74305670 |
| 96 | CDK18 | 0.72403202 |
| 97 | CDK15 | 0.72367591 |
| 98 | STK4 | 0.70439570 |
| 99 | CSNK1G1 | 0.69170295 |
| 100 | BRAF | 0.67702319 |
| 101 | MOS | 0.66752214 |
| 102 | CDK11A | 0.65113061 |
| 103 | PTK2B | 0.63642402 |
| 104 | TIE1 | 0.61798546 |
| 105 | MUSK | 0.61348894 |
| 106 | MAP3K11 | 0.60691985 |
| 107 | PHKG1 | 0.60497911 |
| 108 | PHKG2 | 0.60497911 |
| 109 | IRAK1 | 0.59628987 |
| 110 | PRKCI | 0.58867939 |
| 111 | CSNK2A1 | 0.58357523 |
| 112 | PRKACA | 0.57977433 |
| 113 | GRK6 | 0.57801561 |
| 114 | FER | 0.57711343 |
| 115 | PINK1 | 0.57562533 |
| 116 | KSR2 | 0.57523549 |
| 117 | CSNK2A2 | 0.56339571 |
| 118 | NEK6 | 0.55319573 |
| 119 | PAK6 | 0.52435221 |
| 120 | DAPK3 | 0.52104703 |
| 121 | DYRK1A | 0.51880957 |
| 122 | PBK | 0.51373904 |
| 123 | TNK2 | 0.51355340 |
| 124 | WNK3 | 0.51242858 |
| 125 | VRK1 | 0.49682569 |
| 126 | CSNK1E | 0.48662391 |
| 127 | EIF2AK2 | 0.48587295 |
| 128 | ATM | 0.48323387 |
| 129 | CHEK1 | 0.46473213 |
| 130 | CDK7 | 0.43102704 |
| 131 | MAP3K5 | 0.41807530 |
| 132 | PRKG1 | 0.40274582 |
| 133 | KSR1 | 0.40133389 |
| 134 | INSRR | 0.37893082 |
| 135 | FYN | 0.37117807 |
| 136 | PRPF4B | 0.36949951 |
| 137 | STK10 | 0.36682914 |
| 138 | STK11 | 0.36654405 |
| 139 | ABL2 | 0.36383162 |
| 140 | CDK3 | 0.36126511 |
| 141 | CAMKK2 | 0.35963613 |
| 142 | ERBB4 | 0.35834033 |
| 143 | CSNK1A1L | 0.35661256 |
| 144 | PAK1 | 0.35071426 |
| 145 | PRKCQ | 0.34971397 |
| 146 | RAF1 | 0.34609428 |
| 147 | ILK | 0.34457770 |
| 148 | DAPK1 | 0.34076351 |
| 149 | CAMK1 | 0.33070613 |
| 150 | PRKCA | 0.32162094 |
| 151 | STK3 | 0.31805561 |
| 152 | DYRK3 | 0.31324836 |
| 153 | MAP2K1 | 0.30057821 |
| 154 | CSNK1A1 | 0.27928885 |
| 155 | OBSCN | 0.27523803 |
| 156 | RPS6KA5 | 0.27071717 |
| 157 | AKT3 | 0.26985857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.44284949 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.49938563 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88321739 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.65129838 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.21351744 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.87674626 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.81622976 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.75614950 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.70482744 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.64885459 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.58407075 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51243953 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38401802 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.38053952 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.34448801 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 2.21478522 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.16988836 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.05661921 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.01177241 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98962736 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.97124789 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.96077517 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.92030120 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80497710 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78474844 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.77590124 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74378911 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71872923 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.70739636 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.68308970 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.66904142 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66020215 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.65468241 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62519491 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62363120 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.61657326 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.60458706 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59212374 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.57758637 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.53900748 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.53781723 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52517311 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49807211 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43169272 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.40458100 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39001660 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.38567548 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.37371236 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36421418 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 1.35599467 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31879046 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30917757 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20286487 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19232015 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17442736 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17373801 |
| 57 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16601364 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14753136 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 1.12915840 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11236582 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 1.09798847 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 1.07783629 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07451144 |
| 64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06678457 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06111242 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05524492 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05509966 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00362437 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98349369 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94732033 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.93758562 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88092600 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87844232 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87125632 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86339659 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85610881 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85164865 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.82552515 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81706541 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79996016 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79893531 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.77630201 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.77268705 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77219704 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76301669 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71497267 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68696681 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64616967 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64499451 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.64463875 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63233055 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62057576 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61738489 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61632229 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61127124 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60668147 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59086221 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59054433 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58613756 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58214544 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54519383 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54173085 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52238788 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.51305052 |
| 105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51119060 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50657759 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49154285 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48840452 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.48835415 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46205588 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.45989762 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45415101 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45237404 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42482648 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42450999 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41596144 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40999739 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40391368 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38706726 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38667473 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38452284 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38206866 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38040488 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37681392 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36425841 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35216044 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34201337 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33673219 |
| 129 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31990400 |
| 130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31861038 |
| 131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31685615 |
| 132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30837078 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30584740 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30520738 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29991869 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29743954 |
| 137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29559572 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29464942 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29038692 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27634415 |
| 141 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27466450 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26926810 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26284974 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25134972 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24368189 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24358479 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24007297 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.20997036 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20977301 |
| 150 | RNA polymerase_Homo sapiens_hsa03020 | 0.20286843 |
| 151 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19059648 |
| 152 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18093322 |
| 153 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.18006097 |
| 154 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16699317 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16653388 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16007162 |
| 157 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15801533 |
| 158 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.13355673 |
| 159 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.13314197 |
| 160 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.12430807 |
| 161 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.11779924 |
| 162 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10184116 |
| 163 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.10015882 |
| 164 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.09849883 |
| 165 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09547140 |
| 166 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08659417 |
| 167 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08168835 |
| 168 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07784027 |

